SEC Form 4 · accession 0001434647-26-000073
ZEVRA THERAPEUTICS, INC. · ZVRA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Rahsaan Thompson
Officer — Chief Legal & Compliance
Period of report
Aug 14, 2026
Accepted (ET)
Aug 17, 2026 · 4:32 pm EDT
Rule 10b5-1 plan
yes — trade under a plan
Issuer CIK
0001434647
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Aug 14, 2026 | S | 42,666 | $11.1277 | D | 37,569 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Adoption date of referenced 10b5-1(c) plan is: 05-15-2026
- F2This transaction was executed in multiple trades at prices ranging from $10.86 to $11.36. The price reported reflects the weighted average sale price. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer or any security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.